Literature DB >> 22135159

Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.

Chun-Ming Wong1, Carmen Chak-Lui Wong, Joyce Man-Fong Lee, Dorothy Ngo-Yin Fan, Sandy Leung-Kuen Au, Irene Oi-Lin Ng.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) is a prevalent cancer with an extremely high mortality rate attributed to HCC metastasis, which is the major cause of tumor recurrence and organ failure. Presence of tumor thrombi in the portal veins (venous metastases) is a clinicopathological feature of metastatic HCCs. In this study, we analyzed the microRNA (miRNA) expression profiles of nontumorous livers, primary HCCs, and venous metastases in the same livers from 20 HCC patients by way of TaqMan low-density array (TLDA) and identified the precise alterations of miRNA expression from nontumorous livers to primary HCCs and venous metastases globally. By unsupervised clustering analysis, nontumorous livers were distinctly segregated from primary HCCs and venous metastases, whereas no discernible difference in the expression pattern could be found between primary HCCs and venous metastases. However, a marked global reduction of miRNA expression levels was detected in venous metastases, as compared with primary HCCs. These data suggest that miRNA deregulation is an early event in liver carcinogenesis and the later global miRNA down-regulation aggravates the preexisting miRNA deregulation to further promote HCC metastasis.
CONCLUSION: Our study has enriched the current understanding of the deregulation of miRNAs in HCC progression and highlighted the sequential and distinctive alterations of miRNA expression in primary HCC and venous metastasis formation.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22135159     DOI: 10.1002/hep.25512

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

1.  MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.

Authors:  Felice Ho-Ching Tsang; Sandy Leung-Kuen Au; Lai Wei; Dorothy Ngo-Yin Fan; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

Review 2.  Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.

Authors:  Chun-Ming Wong; Felice Ho-Ching Tsang; Irene Oi-Lin Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-10       Impact factor: 46.802

Review 3.  miRNAs: new tools for molecular classification, diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Angela M Liu; Wei Wang; John M Luk
Journal:  Hepat Oncol       Date:  2014-09-09

Review 4.  miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma.

Authors:  Weiqi Tan; Yang Li; Seng-Gee Lim; Theresa M C Tan
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

Authors:  G X Feng; J Li; Z Yang; S Q Zhang; Y X Liu; W Y Zhang; L H Ye; X D Zhang
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

6.  ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5.

Authors:  Hui-Lung Sun; Ri Cui; JianKang Zhou; Kun-Yu Teng; Yung-Hsuan Hsiao; Kotaro Nakanishi; Matteo Fassan; Zhenghua Luo; Guqin Shi; Esmerina Tili; Huban Kutay; Francesca Lovat; Caterina Vicentini; Han-Li Huang; Shih-Wei Wang; Taewan Kim; Nicola Zanesi; Young-Jun Jeon; Tae Jin Lee; Jih-Hwa Guh; Mien-Chie Hung; Kalpana Ghoshal; Che-Ming Teng; Yong Peng; Carlo M Croce
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

7.  Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.

Authors:  Hao Gu; Xiaodong Guo; Lin Zou; Haiyan Zhu; Jinhui Zhang
Journal:  Mol Cell Biochem       Date:  2013-01-06       Impact factor: 3.396

Review 8.  Non-coding RNAs as therapeutic targets in hepatocellular cancer.

Authors:  Chiara Braconi; Tushar Patel
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

9.  Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.

Authors:  Felice H Tsang; Victor Au; Wen-Jing Lu; Felix H Shek; Angela M Liu; John M Luk; Sheung-Tat Fan; Ronnie T P Poon; Nikki P Lee
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

10.  Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.

Authors:  Xiaomei Zhang; Yunsheng Yang; Xuefeng Liu; James G Herman; Malcolm V Brock; Julien D F Licchesi; Wen Yue; Xuetao Pei; Mingzhou Guo
Journal:  Epigenetics       Date:  2013-02-28       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.